Can you provide an example of a luminal A patient with metastatic breast cancer in whom treatment was optimized by NGS-based, comprehensive genomic assessment?

Can you provide an example of a luminal A patient with metastatic breast cancer in whom treatment was optimized by NGS-based, comprehensive genomic assessment?

Can you provide an example of a luminal A patient with metastatic breast cancer in whom treatment was optimized by NGS-based, comprehensive genomic assessment?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong